Ballentine Partners’s PLDT PHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$435K Buy
24,427
+13,261
+119% +$249K 0.01% 652
2026
Q2
$196K Sell
11,166
-4,825
-30% -$93.4K ﹤0.01% 1014
2026
Q1
$336K Buy
15,991
+3,811
+31% +$86.1K ﹤0.01% 685
2025
Q4
$265K Buy
+12,180
New +$250K ﹤0.01% 775
2025
Q3
– Sell
-12,769
Closed -$278K – 1054
2025
Q2
$278K Sell
12,769
-1,731
-12% -$39.1K ﹤0.01% 719
2025
Q1
$317K Buy
14,500
+52
+0.4% +$1.2K 0.01% 605
2024
Q4
$320K Buy
14,448
+1,610
+13% +$38.2K 0.01% 573
2024
Q3
$345K Buy
12,838
+826
+7% +$22K 0.01% 540
2024
Q2
$295K Sell
12,012
-2,570
-18% -$62K 0.01% 568
2024
Q1
$360K Buy
14,582
+2,753
+23% +$64.3K 0.01% 486
2023
Q4
$277K Buy
+11,829
New +$265K 0.01% 523

Other funds holding PHI

Ballentine Partners's PHI Position: Q3 2026 in Review

Ballentine Partners increased its PLDT (PHI) stake by 119% in Q3 2026, buying an estimated $249K and bringing the position to 24,427 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #652.

Ballentine Partners first reported a position in PHI in Q4 2023 and has held it in 11 quarters since. 101 funds tracked by Wall St. Rank hold PHI as of Q3 2026.

  • Ballentine Partners held 24,427 shares of PLDT worth $435K as of Q3 2026.
  • Ballentine Partners bought 13,261 PLDT shares in Q3 2026, an estimated $249K.
  • PLDT made up 0.01% of Ballentine Partners's portfolio in Q3 2026, its #652 holding.
  • Ballentine Partners first reported a position in PLDT in Q4 2023 and has held it in 11 quarters since.
  • 101 funds tracked by Wall St. Rank held PLDT as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.